| Cited nodes | Nodes / Authors | GCS | LCS |
| 0 | 1 2000 AMERICAN JOURNAL OF NURSING 100(10):114-+
White GB
What we may expect from ethics and the law | | 0
|
| 0 | 2 2000 ANNALS OF NEUROLOGY 48(1):9-10
Fink DJ
Gene therapy for Canavan disease? | | 0
|
| 0 | 3 2000 ARCHIVES DE PEDIATRIE 7(11):1205-1211
Stephan JL
X-linked lymphoproliferative syndrome: from clinical presentation to gene. | | 0
|
| 0 | 4 2000 BIOFUTUR 2000(202):16-20
Kahn A
Ten years of gene therapy: Disappointments and hopes | | 0
|
| 0 | 5 2000 BIOFUTUR 2000(202):30-31
Cohen-Haguenauer O
Development a legal framework for Europe | | 0
|
| 0 | 6 2000 BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE 184(6):1169-1179
Danos O
Gene transfer | 1 | 1
|
| 1 | 7 2000 BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE 184(6):1191-1199
Houssin D
Present and future use of human stem cells in medicine | | 0
|
| 1 | 8 2000 BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE 184(7):1417-1430
Fischer A; Hacein-Bey S; Le Deist F; de Saint Basile G; de Villartay JP; Cavazzana-Calvo M
Gene therapy of immunodeficiency disorders | 1 | 1
|
| 0 | 9 2000 BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE 184(7):1463-1476
Kahn A
From genomics to therapy | | 0
|
| 0 | 10 2000 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 122(2):143-149
Fischer A
Severe combined immunodeficiencies (SCID) | 4 | 2
|
| 0 | 11 2000 COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES 323(12):1167-1174
Kaplan JC; Junien C
Genomics and medicine: an anticipation. From Boolean Mendelian genetics to multifactorial molecular medicine | 1 | 0
|
| 0 | 12 2000 CURRENT OPINION IN HEMATOLOGY 7(6):364-377
Sadelain M; Frassoni F; Riviere I
Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells | 7 | 5
|
| 0 | 13 2000 CURRENT OPINION IN IMMUNOLOGY 12(4):465-467
Leonard WJ
Genetic effects on immunity - Editorial overview | | 0
|
| 0 | 14 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(4):360-361
Carter B; Kohn DB
Clinical applications of gene therapy | | 0
|
| 0 | 15 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(4):376-382
Hackett NR; Kaminsky SM; Sondhi D; Crystal RG
Antivector and antitransgene host responses in gene therapy | 5 | 1
|
| 0 | 16 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(4):400-411
Kurre P; Kiem HP
Progress towards hematopoietic stem cell gene therapy | | 0
|
| 0 | 17 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(4):412-419
Davis BR; Brown DB; Prokopishyn NL; Yannariello-Brown J
Micro-injection-mediated hematopoietic stem cell gene therapy | | 0
|
| 0 | 18 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(4):420-425
Bennett J
Gene therapy for retinitis pigmentosa | | 0
|
| 0 | 19 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(4):433-440
Spencer DM
Developments in suicide genes for preclinical and clinical applications | 6 | 2
|
| 0 | 20 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(5):507-514
Barrette S; Orlic D
Alternative viral envelopes for oncoretroviruses to increase gene transfer into hematopoietic stem cells | 2 | 0
|
| 0 | 21 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(5):540-554
Baekelandt V; De Strooper B; Nuttin B; Debyser Z
Gene therapeutic strategies for neurodegenerative diseases | 2 | 1
|
| 0 | 22 2000 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2(5):570-578
Strayer DS
SV40-based gene therapy vectors: Turning an adversary into a friend | 1 | 0
|
| 0 | 23 2000 CURRENT OPINION IN PEDIATRICS 12(6):555-556
Fuleihan RL
Allergy, immunology, and related disorders | | 0
|
| 1 | 24 2000 CURRENT OPINION IN PEDIATRICS 12(6):557-562
Fischer A
Gene therapy of lymphoid primary immunodeficiencies | 1 | 0
|
| 0 | 25 2000 CYTOKINES CELLULAR & MOLECULAR THERAPY 6(2):97-108
Chabannon C; Olivero S; Blaise D; Maraninchi D; Viens P
Ex vivo expansion of human hematopoietic progenitors and cells to support high-dose chemoradiation therapy: Five years of clinical experience | 1 | 0
|
| 0 | 26 2000 DRUGS OF TODAY 36(9):619-629
Rochlitz CF
Gene therapy of cancer | | 0
|
| 0 | 27 2000 EMBO REPORTS 1(4):294-296
Fischer A
Cautious advance - Gene therapy is more complex than anticipated | | 0
|
| 0 | 28 2000 GENE THERAPY 7(16):1351-1352
Wong-Staal F; Buchschacher GL
Gene therapy and the two faces of HIV | 2 | 0
|
| 0 | 29 2000 GENE THERAPY 7(16):1392-1400
Steinberg M; Swainson L; Schwarz K; Boyer M; Friedrich W; Yssel H; Taylor N; Noraz N
Retrovirus-mediated transduction of primary ZAP-70-deficient human T cells results in the selective growth advantage of gene-corrected cells: implications for gene therapy | 1 | 0
|
| 0 | 30 2000 GENE THERAPY 7(23):1993-1998
Reeves L; Cornetta K
Clinical retroviral vector production: step filtration using clinically approved filters improves titers | 1 | 1
|
| 0 | 31 2000 HUMAN GENE THERAPY 11(14):2051-2056
Otsu M; Sugamura K; Candotti F
In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: Implications for gene therapy | 1 | 1
|
| 1 | 32 2000 HUMAN GENE THERAPY 11(15):2059-2066
Williams DA; Smith FO
Progress in the use of gene transfer methods to treat genetic blood diseases | 7 | 4
|
| 0 | 33 2000 HUMAN GENE THERAPY 11(17):2353-2364
Bunting KD; Lu TH; Kelly PF; Sorrentino BP
Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation | 2 | 2
|
| 0 | 34 2000 HUMAN GENE THERAPY 11(18):2529-2540
Roehl HH; Leibbrandt MEI; Greengard JS; Kamantigue E; Glass WG; Giedlin M; Boekelheide K; Johnson DE; Jolly DJ; Sajjadi NC
Analysis of testes and semen from rabbits treated by intravenous injection with a retroviral vector encoding the human factor VIII gene: No evidence of germ line transduction | 1 | 0
|
| 0 | 35 2000 IMMUNOLOGIC RESEARCH 22(2-3):237-251
Buckley RH
Advances in the understanding and treatment of human severe combined immunodeficiency | | 0
|
| 0 | 36 2000 IMMUNOLOGICAL REVIEWS 178():5-7
Smith CIE
Experiments of nature: primary immune defects deciphered and defeated | | 0
|
| 0 | 37 2000 IMMUNOLOGICAL REVIEWS 178():8-12
Rosen FS
A brief history of immunodeficiency disease | | 0
|
| 0 | 38 2000 IMMUNOLOGICAL REVIEWS 178():13-20
Fischer A; Hacein-Bey S; Le Deist F; Soudais C; Di Santo JP; Basile GD; Cavazzana-Calvo M
Gene therapy of severe combined immunodeficiencies | 6 | 4
|
| 0 | 39 2000 IMMUNOLOGICAL REVIEWS 178():29-38
Heim DA; Dunbar CE
Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency | 5 | 3
|
| 0 | 40 2000 IMMUNOLOGICAL REVIEWS 178():39-48
Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Perez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF
Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model | 3 | 2
|
| 0 | 41 2000 IMMUNOLOGICAL REVIEWS 178():64-74
Santagata S; Villa A; Sobacchi C; Cortes P; Vezzoni P
The genetic and biochemical basis of Omenn syndrome | 1 | 0
|
| 0 | 42 2000 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 41(13):4158-4162
Angella GJ; Sherwood MB; Balasubramanian L; Doyle JW; Smith MF; van Setten G; Goldstein M; Schultz GS
Enhanced short-term plasmid transfection of filtration surgery tissues | 2 | 0
|
| 0 | 43 2000 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 284(21):2788-2788
Ball BG; Anderson WF
Bringing gene therapy to the clinic | 2 | 0
|
| 0 | 44 2000 JOURNAL OF EXPERIMENTAL MEDICINE 192(9):1365-1372
Karanu FN; Murdoch B; Gallacher L; Wu DM; Koremoto M; Sakano S; Bhatia M
The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells | 23 | 1
|
| 0 | 45 2000 JOURNAL OF GENE MEDICINE 2(4):297-300
Fischer A
Gene therapy of severe combined immunodeficiency | | 0
|
| 0 | 46 2000 JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH 9(6):773-782
Glaser VP; Good RA
Investigator profile - Robert A. Good, Ph.D., MD, D.Sc. | | 0
|
| 0 | 47 2000 KENNEDY INSTITUTE OF ETHICS JOURNAL 10(2):171-174
Walters L
The oversight of human gene transfer research | | 0
|
| 0 | 48 2000 LANCET 356(9223):2-4
Horton R
The refiguration of medical thought | 3 | 0
|
| 0 | 49 2000 M S-MEDECINE SCIENCES 16(5):681-684
Borensztein P; Cramer E; Coulombel L; Gilgenkrantz S; Levy Y; Lotteau V
Treatment of an X-linked severe combined immunodeficiency by gamma c-gene transfer | | 0
|
| 0 | 50 2000 M S-MEDECINE SCIENCES 16(11):1275-1278
Aubourg P
Bone marrow transplantation in adrenoleucocystrophia | | 0
|
| 1 | 51 2000 MOLECULAR MEDICINE TODAY 6(10):403-407
Leonard WJ
X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years | 2 | 1
|
| 0 | 52 2000 MOLECULAR THERAPY 2(2):101-102
Bodine D
Globin gene therapy: One (Seemingly) small vector change, one giant leap in optimism | | 0
|
| 0 | 53 2000 MOLECULAR THERAPY 2(5):423-434
Daly G; Chernajovsky Y
Recent developments in retroviral-mediated gene transduction | 3 | 2
|
| 0 | 54 2000 MOLECULAR THERAPY 2(6):609-618
Schilz AJ; Schiedlmeier B; Kuhlcke K; Fruehauf S; Lindemann C; Zeller WJ; Grez M; Fauser AA; Baum C; Eckert HG
MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions | 9 | 7
|
| 0 | 55 2000 NATURE BIOTECHNOLOGY 18(12):1244-1245
Miyanohara A; Friedmann T
Viral vectors do the DNA shuffle | | 0
|
| 0 | 56 2000 NATURE GENETICS 25(4):366-367
Curiel DT
Tailoring vectors through DNA shuffling | | 0
|
| 0 | 57 2000 NATURE MEDICINE 6(6):623-624
Buckley RH
Gene therapy for human SCID: Dreams become reality | 10 | 6
|
| 0 | 58 2000 NATURE MEDICINE 6(6):624-626
Dick JE
Gene therapy turns the corner | 11 | 6
|
| 0 | 59 2000 NATURE MEDICINE 6(8):862-863
Anderson WF
Gene therapy scores against cancer | 10 | 2
|
| 0 | 60 2000 NATURE REVIEWS GENETICS 1(2):91-99
Somia N; Verma IM
Gene therapy: Trials and tribulations | 20 | 8
|
| 0 | 61 2000 NEUROLOGICAL SCIENCES 21(5):S939-S942
Partridge T
The current status of myoblast transfer | 1 | 0
|
| 0 | 62 2000 NEW ENGLAND JOURNAL OF MEDICINE 343(18):1313-1324
Buckley RH
Primary immunodeficiency diseases due to defects in lymphocytes. | 16 | 4
|
| 0 | 63 2000 NURSING CLINICS OF NORTH AMERICA 35(3):757-+
Fibison WJ
Gene therapy | 2 | 0
|
| 0 | 64 2000 PEDIATRIC RESEARCH 48(5):578-578
Kohn DB
Gene therapy for XSCID: The first success of gene therapy | | 0
|
| 0 | 65 2000 PHARMACOLOGICAL REVIEWS 52(4):493-511
Hu WS; Pathak VK
Design of retroviral vectors and helper cells for gene therapy | 2 | 1
|
| 2 | 66 2000 PROGRES EN UROLOGIE 10(5):1021-1051
[Anon]
Gene therapy: Principles and applications in urology | | 0
|
| 0 | 67 2000 PROGRES EN UROLOGIE 10(5):1053-1087
LeRoux N; Cussenot O
Genetics at the centre of the ethical debate? | | 0
|
| 0 | 68 2000 PROSTATE 45(2):167-172
Shah AH; Lee C
TGF-beta-based immunotherapy for cancer: Breaching the tumor firewall | 6 | 0
|
| 0 | 69 2000 SCIENCE 288(5466):627-+
Anderson WF
Gene therapy - The best of times, the worst of times | 12 | 7
|
| 0 | 70 2000 SCIENCE 288(5466):669-672
Cavazzana-Calvo M; Hacein-Bey S; Basile CD; Gross F; Yvon E; Nusbaum P; Selz F; Hue C; Certain S; Casanova JL; Bousso P; Le Deist F; Fischer A
Gene therapy of human severe combined immunodeficiency (SCID)- X1 disease | 278 | 0
|
| 0 | 71 2000 SCIENCE 290(5495):1308-1309
Willard HF
Genomics and gene therapy - Artificial chromosomes coming to life | 11 | 3
|
| 0 | 72 2000 SCIENTIST 14(13):8-9
Bunk S
Gene therapy soldiers on | | 0
|
| 0 | 73 2000 STEM CELLS 18(5):374-381
Rosu-Myles M; Khandaker M; Wu DM; Keeney M; Foley SR; Howson-Jan K; Yee IC; Fellows F; Kelvin D; Bhatia M
Characterization of chemokine receptors expressed in primitive blood cells during human hematopoietic ontogeny | 1 | 0
|
| 0 | 74 2001 ACADEMIC MEDICINE 76(1):32-38
Szebik I; Glass KC
Ethical issues of human germ-cell therapy: A preparation for public discussion | 2 | 0
|
| 0 | 75 2001 ACADEMIC RADIOLOGY 8(1):15-23
Bremer C; Weissleder R
Molecular imaging - In vivo imaging of gene expression: MR and optical technologies | 7 | 0
|
| 0 | 76 2001 ADVANCED DRUG DELIVERY REVIEWS 49(1-2):107-119
Kagawa Y; Inoki Y; Endo H
Gene therapy by mitochondrial transfer | 2 | 0
|
| 0 | 77 2001 AMERICAN FAMILY PHYSICIAN 63(9):1707-+
Dean DA; Perkin RA
Gene therapy: If at first you don't succeed ... | | 0
|
| 0 | 78 2001 AMERICAN JOURNAL OF MEDICAL GENETICS 98(1):46-56
Fanos JH; Davis J; Puck JM
Sib understanding of genetics and attitudes toward carrier testing for X-linked severe combined immunodeficiency | 1 | 0
|
| 0 | 79 2001 AMERICAN JOURNAL OF MEDICAL GENETICS 98(1):57-63
Fanos JH; Puck JM
Family pictures: Growing up with a brother with X-linked severe combined immunodeficiency | | 0
|
| 0 | 80 2001 AMERICAN JOURNAL OF ROENTGENOLOGY 176(6):1541-1552
Yin EZ; Frush DP; Donnelly LF; Buckley RH
Primary immunodeficiency disorders in pediatric patients: Clinical features and imaging findings | 1 | 1
|
| 2 | 81 2001 ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 87(5):362-369
Tangsinmankong N; Bahna SL; Good RA
The immunologic workup of the child suspected of immunodeficiency | | 0
|
| 1 | 82 2001 ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS 2():177-211
Pfeifer A; Verma IM
Gene therapy: Promises and problems | 2 | 1
|
| 0 | 83 2001 ARCHIVES OF DISEASE IN CHILDHOOD 84(2):169-173
Gaspar HB; Gilmour KC; Jones AM
Severe combined immunodeficiency - molecular pathogenesis and diagnosis | | 0
|
| 0 | 84 2001 ARCHIVES OF NEUROLOGY 58(11):1793-1798
Sondhi D; Hackett NR; Apblett RL; Kaminsky SM; Pergolizzi RG; Crystal RG
Feasibility of gene therapy for late neuronal ceroid lipofuscinosis | | 0
|
| 0 | 85 2001 ARCHIVES OF VIROLOGY 146(3):601-609
Malik AK; Wang JM; Kurachi K
Effects of a second intron on recombinant MFG retroviral vector - Brief report | | 0
|
| 0 | 86 2001 BEHAVIORAL SCIENCES & THE LAW 19(3):405-421
Petrila J
Genetic risk: The new frontier for the duty to warn | | 0
|
| 0 | 87 2001 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 14(4):671-683
Flake AW
In utero transplantation of haemopoietic stem cells | | 0
|
| 1 | 88 2001 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 14(4):823-834
Fairbairn LJ; Ewing JC
Prospects for gene therapy using haemopoietic stem cells | | 0
|
| 0 | 89 2001 BIOCONJUGATE CHEMISTRY 12(6):906-910
Cheung CY; Murthy N; Stayton PS; Hoffman AS
A pH-sensitive polymer that enhances cationic lipid-mediated gene transfer | 1 | 0
|
| 0 | 90 2001 BIODRUGS 15(10):635-644
Takeda S; Miyagoe-Suzuki Y
Gene therapy for muscular dystrophies - Current status and future prospects | | 0
|
| 1 | 91 2001 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 7(3):123-135
Good RA; Verjee T
Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities | 1 | 0
|
| 0 | 92 2001 BIOMEDICINE & PHARMACOTHERAPY 55(7):353-361
Okano M
Epstein-Barr virus in patients with immunodeficiency disorders | | 0
|
| 0 | 93 2001 BIOTECHNOLOGY PROGRESS 17(2):240-246
Kwon YJ; Peng CA
Impact of cell growth morphology on retroviral transduction: Effect of contact inhibition | 1 | 0
|
| 0 | 94 2001 BIOTECHNOLOGY PROGRESS 17(4):587-596
Bajaj B; Lei P; Andreadis ST
High efficiencies of gene transfer with immobilized recombinant retrovirus: Kinetics and optimization | | 0
|
| 1 | 95 2001 BLOOD 97(6):1618-1624
Otsu M; Sugamura K; Candotti F
Lack of dominant-negative effects of a truncated gamma c on retroviral-mediated gene correction of immunodeficient mice | 1 | 1
|
| 0 | 96 2001 BLOOD 97(9):2896-2899
Ariga T; Oda N; Yamaguchi K; Kawamura N; Kikuta H; Taniuchi S; Kobayashi Y; Terada K; Ikeda H; Hershfield MS; Kobayashi K; Sakiyama Y
T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation | 2 | 2
|
| 0 | 97 2001 BLOOD 97(11):3417-3423
Tran ND; Porada CD; Almeida-Porada G; Glimp HA; Anderson WF; Zanjani ED
Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses | 1 | 1
|
| 0 | 98 2001 BLOOD 98(2):398-404
Nielsen SD; Jeppesen DL; Kolte L; Clark DR; Sorensen TU; Dreves AM; Ersboll AK; Ryder LP; Valerius NH; Nielsen JO
Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts | | 0
|
| 0 | 99 2001 BONE MARROW TRANSPLANTATION 28(3):227-233
Denianke KS; Frieden IJ; Cowan MJ; Williams ML; McCalmont TH
Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: a clinicopathologic study | | 0
|
| 0 | 100 2001 BRITISH JOURNAL OF CANCER 85(10):1432-1436
Galanis E; Russell S
Cancer gene therapy clinical trials: lessons for the future | | 0
|
| 0 | 101 2001 BRITISH JOURNAL OF HAEMATOLOGY 112(3):671-676
Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency | 1 | 0
|
| 0 | 102 2001 BRITISH JOURNAL OF HAEMATOLOGY 112(4):1004-1011
Ting SS; Tangye SG; Wood J; Ffrench RA; Ziegler JB
Reduced memory B-cell populations in boys with B-cell dysfunction after bone marrow transplantation for X-linked severe combined immunodeficiency | 1 | 0
|
| 2 | 103 2001 BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE 185(8):1539-1560
Ardaillou R
Gene therapy: present evaluation and prospects | | 0
|
| 0 | 104 2001 CANCER GENE THERAPY 8(9):669-676
Beausejour CM; Eliopoulos N; Momparler L; Le NLO; Momparler RL
Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene | | 0
|
| 1 | 105 2001 CANCER RESEARCH 61(13):5116-5125
Kobune M; Xu Y; Baum C; Kelley MR; Williams DA
Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N ',N ''-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo | 2 | 0
|
| 2 | 106 2001 CELLULAR AND MOLECULAR BIOLOGY 47(8):1269-1275
Fischer A
Gene therapy: Some results, many problems to solve | | 0
|
| 1 | 107 2001 CELLULAR AND MOLECULAR BIOLOGY 47(8):1277-1294
Meyer F; Finer M
Gene therapy: Progress and challenges | | 0
|
| 0 | 108 2001 CHINESE SCIENCE BULLETIN 46(18):1534-1538
Wang HW; Ye CB; Chen L; Wang XF; Qiu XF; Xue JL; Lu D
Efficient transfer and expression of human clotting factor IX cDNA in neonatal hemophilia B mice mediated by VSV-G pseudotyped retrovirus | | 0
|
| 0 | 109 2001 CURRENT DRUG TARGETS 2(4):371-399
Johnson-Saliba M; Jans DA
Gene therapy: Optimising DNA delivery to the nucleus | | 0
|
| 5 | 110 2001 CURRENT OPINION IN HEMATOLOGY 8(6):360-367
Cavazzana-Calvo M; Hacein-Bey-Abina S
Correction of genetic blood defects by gene transfer | | 0
|
| 0 | 111 2001 CURRENT OPINION IN MOLECULAR THERAPEUTICS 3(2):125-132
Hadlaczky G
Satellite DNA-based artificial chromosomes for use in gene therapy | 1 | 0
|
| 2 | 112 2001 CURRENT OPINION IN MOLECULAR THERAPEUTICS 3(4):357-361
Cartier N
Gene therapy strategies for X-linked adrenoleukodystrophy | | 0
|
| 1 | 113 2001 CURRENT OPINION IN MOLECULAR THERAPEUTICS 3(5):439-453
Weber E; Anderson WF; Kasahara N
Recent advances in retrovirus vector-mediated gene therapy: Teaching an old vector new tricks | 3 | 1
|
| 4 | 114 2001 CURRENT OPINION IN MOLECULAR THERAPEUTICS 3(5):468-475
Chang LJ; He J
Retroviral vectors for gene therapy of AIDS and cancer | | 0
|
| 0 | 115 2001 CURRENT OPINION IN MOLECULAR THERAPEUTICS 3(5):491-496
Srivastava A
Parvovirus vectors for human gene therapy | | 0
|
| 0 | 116 2001 CURRENT OPINION IN PEDIATRICS 13(6):528-532
Fuleihan RL
Hyper IgM syndrome: the other side of the coin | | 0
|
| 0 | 117 2001 CURRENT SCIENCE 81(5):555-560
Mulherkar R
Gene therapy for cancer | | 0
|
| 1 | 118 2001 CYTOKINE 14(2):63-77
Gaffen SL
Signaling domains of the interleukin 2 receptor | | 0
|
| 0 | 119 2001 CYTOTHERAPY 3(2):67-84
Moritz T; Williams DA
Marrow protection - transduction of hematopoietic cells with drug resistance genes | | 0
|
| 0 | 120 2001 DRUG DISCOVERY TODAY 6(2):92-101
Page DT; Cudmore S
Innovations in oral gene delivery: challenges and potentials | 3 | 0
|
| 0 | 121 2001 DRUG DISCOVERY TODAY 6(9):463-470
Anchordoquy TJ; Allison SD; Molina MDC; Girouard LG; Carson TK
Physical stabilization of DNA-based therapeutics | 2 | 0
|
| 0 | 122 2001 DRUG DISCOVERY TODAY 6(13):689-697
Liau G; Su EJ; Dixon KD
Clinical efforts to modulate angiogenesis in the adult: gene therapy versus conventional approaches | 1 | 0
|
| 0 | 123 2001 EXPERIMENTAL HEMATOLOGY 29(2):163-173
Newbound GC; Cooper JR; O'Rourke JP; Baskin CR; Bunnell BA
Analysis of gene transfer efficiency of retrovirus producer cell transplantation for in situ gene transfer to hematopoietic cells | | 0
|
| 0 | 124 2001 EXPERIMENTAL HEMATOLOGY 29(5):543-556
Jahagirdar BN; Miller JS; Shet A; Verfaillie CM
Novel therapies for chronic myelogenous leukemia | 1 | 0
|
| 0 | 125 2001 EXPERIMENTAL HEMATOLOGY 29(6):779-785
Giri N; Kaushiva A; Wu T; Sellers SE; Tisdale JF
The effects of SCF/G-CSF prestimulation on radiation sensitivity and engraftment in nonmyeloablated murine hosts | 1 | 1
|
| 0 | 126 2001 EXPERIMENTAL HEMATOLOGY 29(11):1326-1335
Berrios VM; Dooner GJ; Nowakowski G; Frimberger A; Valinski H; Quesenberry PJ; Becker PS
The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells | | 0
|
| 0 | 127 2001 EXPERT OPINION ON BIOLOGICAL THERAPY 1(1):17-40
Pandya S; Klimatcheva E; Planelles V
Lentivirus and foamy virus vectors: novel gene therapy tools | | 0
|
| 0 | 128 2001 EXPERT OPINION ON BIOLOGICAL THERAPY 1(2):205-212
Jones D
In utero stem cell transplantation: two steps forward but one step back? | | 0
|
| 0 | 129 2001 EXPERT OPINION ON BIOLOGICAL THERAPY 1(5):857-867
Novelli EM; Barranger JA
Gene therapy for lysosomal storage disorders | | 0
|
| 0 | 130 2001 FASEB JOURNAL 15(8):U533-U546
Guidotti JE; Mallet VO; Mitchell C; Fabre M; Schoevaert D; Opolon P; Parlier D; Lambert M; Kahn A; Gilgenkrantz H
Selection of in vivo retrovirally transduced hepatocytes leads to efficient and predictable mouse liver repopulation | | 0
|
| 0 | 131 2001 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 25(3):273-286
Gerolami R; Uch R; Cardoso J; Bagnis C; Mannoni P; Brechot C
Gene therapy for hepatocellular carcinoma. From the idea to clinical trials | | 0
|
| 0 | 132 2001 GENE THERAPY 8(6):431-441
Pastorino S; Massazza S; Cilli M; Varesio L; Bosco MC
Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer | 2 | 0
|
| 0 | 133 2001 GENE THERAPY 8(8):618-626
Fontanellas A; Mendez M; Mazurier F; Cario-Andre M; Navarro S; Ged C; Taine L; Geronimi F; Richard E; Moreau-Gaudry F; de Salamanca RE; de Verneuil H
Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells | 1 | 1
|
| 0 | 134 2001 GENE THERAPY 8(10):784-788
Heikkila A; Hiltunen MO; Turunen MP; Keski-Nisula L; Turunen AM; Rasanen H; Rissanen TT; Kosma VM; Manninen H; Heinonen S; Yla-Herttuala S
Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes | | 0
|
| 0 | 135 2001 GENE THERAPY 8(10):811-817
Klump H; Schiedlmeier B; Vogt B; Ryan M; Ostertag W; Baum C
Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy | | 0
|
| 0 | 136 2001 GUT 48(5):733-736
Young LS; Mautner V
The promise and potential hazards of adenovirus gene therapy | 2 | 1
|
| 0 | 137 2001 GYNAKOLOGE 34(12):1182-+
Hallek M; Buening H; Ried M; Hacker U; Kurzeder C; Wendtner CM
Basics of gene therapy. Principles and development status | | 0
|
| 0 | 138 2001 HARVARD INTERNATIONAL LAW JOURNAL 42(1):47-139
Murphy SD
Biotechnology and international law | | 0
|
| 0 | 139 2001 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 15(3):497-+
Ferrer FA; Rodriguez R
Prostate cancer gene therapy | | 0
|
| 0 | 140 2001 HUMAN GENE THERAPY 12(1):35-44
Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
Simplified retroviral vector GCsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice | 1 | 0
|
| 0 | 141 2001 HUMAN GENE THERAPY 12(3):291-301
Hacein-Bey S; Gross F; Nusbaum P; Hue C; Hamel Y; Fischer A; Cavazzana-Calvo M
Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells | 4 | 0
|
| 0 | 142 2001 HUMAN GENE THERAPY 12(6):607-617
Donahue RE; Dunbar CE
Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells | 4 | 3
|
| 0 | 143 2001 HUMAN GENE THERAPY 12(9):1013-1019
Buchschacher GL; Wong-Staal F
Approaches to gene therapy for human immunodeficiency virus infection | 4 | 2
|
| 0 | 144 2001 HUMAN GENE THERAPY 12(9):1079-1089
Gatlin J; Padgett A; Melkus MW; Kelly PF; Garcia JV
Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34(+) cells transduced by a self-inactivating human immunodeficiency virus type 1 vector | 3 | 2
|
| 2 | 145 2001 HUMAN GENE THERAPY 12(12):1483-1484
Anderson WF
Excitement in gene therapy! | | 0
|
| 1 | 146 2001 HUMAN GENE THERAPY 12(13):1663-1672
Kang E; Giri N; Wu T; Sellers S; Kirby M; Hanazono Y; Tisdale J; Dunbar CE
In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting | | 0
|
| 1 | 147 2001 HUMAN GENE THERAPY 12(16):1979-1988
Dando JS; Roncarolo MG; Bordignon C; Aiuti A
A novel human packaging cell line with hematopoietic supportive capacity increases gene transfer into early hematopoietic progenitors | | 0
|
| 4 | 148 2001 HUMAN GENE THERAPY 12(17):2095-2108
Pollok KE; van der Loo JCM; Cooper RJ; Hartwell JR; Miles KR; Breese R; Williams EP; Montel A; Seshadri R; Hanenberg H; Williams DA
Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony- stimulating factor-mobilized peripheral blood | 1 | 0
|
| 0 | 149 2001 HUMAN REPRODUCTION UPDATE 7(1):85-91
Surbek DV; Holzgreve W; Nicolaides KH
Haematopoietic stem cell transplantation and gene therapy in the fetus: ready for clinical use? | 1 | 0
|
| 6 | 150 2001 IMMUNITY 15(1):1-4
Fischer A; Hacein-Bey S; Le Deist F; de Saint Basile G; Cavazzana-Calvo M
Gene therapy for human severe combined immunodeficiencies | | 0
|
| 1 | 151 2001 INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN 28(3):150-158
Surbek DV; Schatt S; Holzgreve W
Stem cell transplantation and gene therapy in utero | | 0
|
| 2 | 152 2001 INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE 46(3):169-183
Greene RA; Jenkins TM; Wapner R
The new genetic era in reproductive medicine: Possibilities, probabilities and problems | | 0
|
| 0 | 153 2001 INTERNATIONAL JOURNAL OF HEALTH SERVICES 31(2):445-461
Holtzman NA
Putting the search for genes in perspective | 1 | 0
|
| 0 | 154 2001 INTERNATIONAL JOURNAL OF HEMATOLOGY 73(2):162-169
Richter J; Karlsson S
Clinical gene therapy in hematology: Past and future | 3 | 3
|
| 0 | 155 2001 INTERNIST 42(10):1306-+
Hallek M; Buening H; Ried M; Hacker U; Kurzeder C; Wendtner CM
Principles of gene therapy - Issues and status of development | | 0
|
| 0 | 156 2001 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 285(5):540-544
Collins FS; McKusick VA
Implications of the Human Genome Project for medical science | 33 | 1
|
| 0 | 157 2001 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 285(5):545-550
Kaji EH; Leiden JM
Gene and stem cell therapies | 2 | 0
|
| 1 | 158 2001 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 285(5):551-555
Bumol TF; Watanabe AM
Genetic information, genomic technologies, and the future of drug discovery | 2 | 0
|
| 1 | 159 2001 JOINT BONE SPINE 68(2):109-111
Boissier MC
Ethical aspects of gene therapy in rheumatology | | 0
|
| 1 | 160 2001 JOURNAL OF CLINICAL INVESTIGATION 108(3):447-455
Takatoku M; Sellers S; Agricola BA; Metzger ME; Kato I; Donahue RE; Dunbar CE
Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates | 9 | 4
|
| 0 | 161 2001 JOURNAL OF DRUG TARGETING 9(6):485-494
Hoque ATMS; Yamano S; Baccaglini L; Baum BJ
Using salivary glands as a tissue target for gene therapeutics | | 0
|
| 0 | 162 2001 JOURNAL OF EXPERIMENTAL MEDICINE 194(5):591-599
Almeida ARM; Borghans JAM; Freitas AA
T cell homeostasis: Thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors | 2 | 0
|
| 0 | 163 2001 JOURNAL OF GENE MEDICINE 3(1):21-31
Spirito F; Meneguzzi G; Danos O; Mezzina M
Cutaneous gene transfer and therapy: the present and the future | 4 | 0
|
| 0 | 164 2001 JOURNAL OF GENE MEDICINE 3(3):201-206
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
Gene therapy of severe combined immunodeficiencies | 1 | 0
|
| 2 | 165 2001 JOURNAL OF GENE MEDICINE 3(5):427-436
Schilz AJ; Kuhlcke K; Fauser AA; Eckert HG
Optimization of retroviral vector generation for clinical application | | 0
|
| 0 | 166 2001 JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH 10(2):321-322
Srivastava A
Gene therapy with viral vectors: The hope, the problems, and the solution | | 0
|
| 0 | 167 2001 JOURNAL OF IMMUNOLOGY 167(4):2379-2387
Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM
Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit | 4 | 0
|
| 2 | 168 2001 JOURNAL OF INHERITED METABOLIC DISEASE 24():25-41
Siatskas C; Medin JA
Gene therapy for Fabry disease | 1 | 1
|
| 0 | 169 2001 JOURNAL OF INTERNAL MEDICINE 249(4):327-328
Gahrton G
Haematopoietic cell gene therapy - Introduction | | 0
|
| 0 | 170 2001 JOURNAL OF INTERNAL MEDICINE 249(4):329-338
Dunbar CE
The use of nonhuman primate models to improve gene transfer into haematopoietic stem cells | | 0
|
| 0 | 171 2001 JOURNAL OF INTERNAL MEDICINE 249(4):345-358
Brenner MK
Gene transfer and the treatment of haematological malignancy | 3 | 1
|
| 0 | 172 2001 JOURNAL OF INTERNAL MEDICINE 249(4):379-390
Kohn DB
Gene therapy for genetic haematological disorders and immunodeficiencies | 1 | 0
|
| 0 | 173 2001 JOURNAL OF INTERNAL MEDICINE 250(5):367-368
Yla-Herttuala S
Gene therapy for coronary heart disease | | 0
|
| 1 | 174 2001 JOURNAL OF NUCLEAR MEDICINE 42(8):1235-1237
Boerman OC; Oyen WJG; Corstens FHM
Progress in gene therapy: Seeing is believing | | 0
|
| 0 | 175 2001 JOURNAL OF PHYSIOLOGY-PARIS 95(1-6):325-335
Szabo S; Deng XM; Khomenko T; Yoshida M; Jadus MR; Sandor Z; Gombos Z; Matsumoto H
Gene expression and gene therapy in experimental duodenal ulceration | | 0
|
| 0 | 176 2001 JOURNAL OF THE NATIONAL CANCER INSTITUTE 93(13):1014-1020
Feldman AL; Alexander HR; Hewitt SM; Lorang D; Thiruvathukal CE; Turner EM; Libutti SK
Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors | 5 | 1
|
| 0 | 177 2001 JOURNAL OF VIROLOGY 75(2):799-808
Berger C; Huang ML; Gough M; Greenberg PD; Riddell SR; Kiem HP
Nonmyeloablative immunosuppressive regimen prolongs in vivo persistence of gene-modified autologous T cells in a nonhuman primate model | 1 | 0
|
| 0 | 178 2001 JOURNAL OF VIROLOGY 75(8):3547-3555
An DS; Kung SKP; Bonifacino A; Wersto RP; Metzger ME; Agricola BA; Mao SH; Chen ISY; Donahue RE
Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques | 2 | 1
|
| 0 | 179 2001 JOURNAL OF VIROLOGY 75(13):6218-6222
Carstanjen D; Dutt P; Moritz T
Heparin inhibits retrovirus binding to fibronectin as well as retrovirus gene transfer on fibronectin fragments | | 0
|
| 0 | 180 2001 LANCET 357(9271):1863-1869
Fischer A
Primary immunodeficiency diseases: an experimental model for molecular medicine | 5 | 2
|
| 0 | 181 2001 LEUKEMIA 15(4):523-544
Van Tendeloo VFI; Van Broeckhoven C; Berneman ZN
Gene therapy: principles and applications to hematopoietic cells | 1 | 0
|
| 0 | 182 2001 MEDICINA CLINICA 117(20):778-780
Barquinero J; Escarp MG
Stem cell gene therapy: myths an realities | | 0
|
| 0 | 183 2001 MEMORIAS DO INSTITUTO OSWALDO CRUZ 96(3):415-425
Tosta CE
Coevolutionary networks: a novel approach to understanding the relationships of humans with the infectious agents | 1 | 0
|
| 0 | 184 2001 MOLECULAR THERAPY 3(3):411-417
Mazurier F; Geronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
Correction of deficient CD34(+) cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria | 1 | 1
|
| 0 | 185 2001 MOLECULAR THERAPY 3(4):438-448
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guetard D; Pflumio F; Dubart-Kupperschmitt A
Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified TRIP lentiviral vectors | 8 | 4
|
| 0 | 186 2001 MOLECULAR THERAPY 3(4):516-525
McCormack JE; Edwards W; Sensintaffer J; Lillegren L; Kozloski M; Brumm D; Karavodin L; Jolly DJ; Greengard J
Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector | 3 | 0
|
| 0 | 187 2001 MOLECULAR THERAPY 3(4):543-550
Stover ML; Wang CKL; McKinstry MB; Kalajzic I; Gronowicz G; Clark SH; Rowe DW; Lichtler AC
Bone-directed expression of Col1a1 promoter-driven self- inactivating retroviral vector in bone marrow cells and transgenic mice | 2 | 0
|
| 0 | 188 2001 MOLECULAR THERAPY 3(4):565-573
Mendoza GJA; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model | | 0
|
| 0 | 189 2001 MOLECULAR THERAPY 3(6):867-874
Vorup-Jensen T; Jensen UB; Liu H; Kawasaki T; Uemura K; Thiel S; Dagnaes-Hansen F; Jensen TG
Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver | 1 | 0
|
| 0 | 190 2001 MOLECULAR THERAPY 3(6):911-919
Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the Fanconi anemia C gene after conditioning with low-dose irradiation | 1 | 0
|
| 0 | 191 2001 MOLECULAR THERAPY 4(1):58-65
Koehler DR; Hannam V; Belcastro R; Steer B; Wen YX; Post M; Downey G; Tanswell AK; Hu J
Targeting transgene expression for cystic fibrosis gene therapy | 1 | 0
|
| 0 | 192 2001 MOLECULAR THERAPY 4(3):223-231
Hemminki A; Belousova N; Zinn KR; Liu B; Wang MH; Chaudhuri TR; Rogers BE; Buchsbaum DJ; Siegal GP; Barnes MN; Gomez-Navarro J; Curiel DT; Alvarez RD
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression | 3 | 2
|
| 0 | 193 2001 MOLECULAR THERAPY 4(3):273-279
Thaler S; Schnierle BS
A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes | | 0
|
| 2 | 194 2001 MOLECULAR THERAPY 4(4):331-338
Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-Andre M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F
Gene therapy of a mouse model of protoporphyria with a self- inactivating erythroid-specific lentiviral vector without preselection | 2 | 0
|
| 0 | 195 2001 MONATSSCHRIFT KINDERHEILKUNDE 149(3):270-280
Rosenecker J; Rudolph C
Gene therapy of cystic fibrosis | | 0
|
| 0 | 196 2001 NATURE MEDICINE 7(1):33-40
Kay MA; Glorioso JC; Naldini L
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics | 50 | 12
|
| 0 | 197 2001 NEW VISTAS IN THERAPEUTICS, FROM DRUG DESIGN TO GENE THERAPY: DRUG-RESISTANT TUBERCULOSIS, FROM MOLECULES TO MACRO-ECONOMICS 953():26-30
Scollay R
Gene therapy - A brief overview of the past, present, and future | 1 | 0
|
| 0 | 198 2001 NEW VISTAS IN THERAPEUTICS, FROM DRUG DESIGN TO GENE THERAPY: DRUG-RESISTANT TUBERCULOSIS, FROM MOLECULES TO MACRO-ECONOMICS 953():64-74
High KA
AAV-mediated gene transfer for hemophilia | | 0
|
| 0 | 199 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(6):3428-3433
Qin GJ; Takenaka T; Telsch K; Kelley L; Howard T; Levade T; Deans R; Howard BH; Malech HL; Brady RO; Medin JA
Preselective gene therapy for Fabry disease | 4 | 2
|
| 1 | 200 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(23):13282-13287
Kim IH; Jozkowicz A; Piedra PA; Oka K; Chan L
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector | 1 | 0
|
| 1 | 201 2001 QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS 94(7):337-339
Grainger DJ
Human gene therapy: are we still expecting too much, too soon? | | 0
|
| 0 | 202 2001 SEMINARS IN HEMATOLOGY 38(3):268-275
Russell SJ; Dunbar CE
Gene therapy approaches for multiple myeloma | 1 | 1
|
| 1 | 203 2001 SEMINARS IN HEMATOLOGY 38(4):382-392
Tisdale J; Sadelain M
Toward gene therapy for disorders of globin synthesis | 2 | 2
|
| 0 | 204 2001 STEM CELLS 19(1):12-23
Hanazono Y; Terao K; Ozawa K
Gene transfer into nonhuman primate hematopoietic stem cells: Implications for gene therapy | 1 | 0
|
| 0 | 205 2001 STEM CELLS 19(2):118-124
Hawley TS; Telford WG; Hawley RG
"Rainbow" reporters for multispectral marking and lineage analysis of hematopoietic stem cells | 2 | 0
|
| 0 | 206 2001 STEM CELLS 19(3):247-259
Gao ZG; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector | 4 | 2
|
| 0 | 207 2001 STEM CELLS 19(5):358-377
Burton EA; Wechuck JB; Wendell SK; Goins WF; Fink DJ; Glorioso JC
Multiple applications for replication-defective herpes simplex virus vectors | 2 | 0
|
| 0 | 208 2001 STP PHARMA SCIENCES 11(1):21-30
Rozenberg Y; Medvedkin V; Wang J; Shen WC
Alternative gene delivery | | 0
|
| 0 | 209 2001 SWISS MEDICAL WEEKLY 131(1-2):4-9
Rochlitz CF
Gene therapy of cancer | 1 | 0
|
| 1 | 210 2001 TRENDS IN MOLECULAR MEDICINE 7(6):235-237
Choo KHA
Engineering human chromosomes for gene therapy studies | 2 | 0
|
| 2 | 211 2001 WORLD JOURNAL OF GASTROENTEROLOGY 7(6):752-759
Xu CT; Huang LT; Pan BR
Current gene therapy for stomach carcinoma | 2 | 0
|
| 0 | 212 2002 ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 26(4):582-585
Israel Y; Crews FT; Thurman RG; Tu GC; Garver E; Ponnappa B; Karahanian E; Rubin R; Hoplight B; Sethna M; Hanes R; Wilkie MB; Wheeler MD
Gene and antisense delivery in alcoholism research | | 0
|
| 1 | 213 2002 AMERICAN BIOLOGY TEACHER 64(4):264-270
Simon EJ
Human gene therapy: Genes without frontiers? | | 0
|
| 1 | 214 2002 BIODRUGS 16(2):77-87
Hemminki A; Alvarez RD
Adenoviruses in oncology - A viable option? | | 0
|
| 0 | 215 2002 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 8(4):188-197
Hartnett BJ; Yao DP; Suter SE; Ellinwood NM; Henthorn PS; Moore PF; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
Transplantation of X-linked severe combined immunodeficient dogs with CD34(+) bone marrow cells | | 0
|
| 2 | 216 2002 BLOOD 99(2):399-408
Cui Y; Golob J; Kelleher E; Ye ZH; Pardoll D; Cheng LZ
Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells | 2 | 0
|
| 1 | 217 2002 BLOOD 99(2):709-712
Scherr M; Battmer K; Blomer U; Schiedlmeier B; Ganser A; Grez M; Eder M
Lentiviral gene transfer into peripheral blood-derived CD34(+) NOD/SCID-repopulating cells | | 0
|
| 0 | 218 2002 BLOOD 99(3):872-878
Myers LA; Patel DD; Puck JM; Buckley RH
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival | 1 | 1
|
| 1 | 219 2002 BLOOD 99(3):1005-1013
Arredondo-Vega FX; Santisteban I; Richard E; Bali P; Koleilat M; Loubser M; Al-Ghonaium A; Al-Helali M; Hershfield MS
Adenosine deaminase deficiency with mosaicism for a "second- site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy | | 0
|
| 4 | 220 2002 BLOOD 99(6):1902-1908
May C; Rivella S; Chadburn A; Sadelain M
Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene | 1 | 1
|
| 3 | 221 2002 BRITISH JOURNAL OF HAEMATOLOGY 117(1):23-32
Schmidt-Wolf IGH
Immunomodulatory gene therapy for haematological malignancies | | 0
|
| 0 | 222 2002 BULLETIN DU CANCER 89(1):75-88
Ugo V; Legrand O; Delmer A; Rio B; Casadevall N; Marie JP
What's, new in neoplastic diseases of the hematopoietic and lymphoid tissues | | 0
|
| 0 | 223 2002 CANCER INVESTIGATION 20(1):124-138
Schwarzenberger P; Kolls JK; La Russa V
Hematopoietic stem cells | | 0
|
| 1 | 224 2002 CANCER RESEARCH 62(5):1266-1270
Bauerschmitz GJ; Lam JT; Kanerva A; Suzuki K; Nettelbeck DM; Dmitriev I; Krasnykh V; Mikheeva GV; Barnes MN; Alvarez RD; Dall P; Alemany R; Curiel DT; Hemminki A
Treatment of ovarian cancer with a tropism modified oncolytic adenovirus | 1 | 0
|
| 0 | 225 2002 CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY 25(2):98-108
Manninen HI; Makinen K
Gene therapy techniques for peripheral arterial disease | | 0
|
| 2 | 226 2002 CHEMISTRY & INDUSTRY (4):16-18
Afione S; Kotin R
Gene transfer on target | | 0
|
| 1 | 227 2002 EUROPEAN JOURNAL OF BIOCHEMISTRY 269(5):1490-1499
Zhang JL; Buehner M; Sebald W
Functional epitope of common gamma chain for interleukin-4 binding | | 0
|
| 0 | 228 2002 EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (7):1271-1277
Roosjen A; Smisterova J; Driessen C; Anders JT; Wagenaar A; Hoekstra D; Hulst R; Engberts JBFN
Synthesis and characteristics of biodegradable pyridinium amphiphiles used for in vitro DNA delivery | | 0
|
| 0 | 229 2002 EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (8):1397-1406
Buijnsters PJJA; Rodriguez CLG; Willighagen EL; Sommerdijk NAJM; Kremer A; Camilleri P; Feiters MC; Nolte RJM; Zwanenburg B
Cationic gemini Surfactants based on tartaric acid: Synthesis, aggregation, monolayer behaviour, and interaction with DNA | | 0
|
| 3 | 230 2002 EXPERIMENTAL HEMATOLOGY 30(1):11-17
Tahara-Hanaoka S; Sudo K; Ema H; Miyoshi H; Nakauchi H
Lentiviral vector-mediated transduction of murine CD34(-) hematopoietic stem cells | | 0
|
| 0 | 231 2002 EXPERIMENTAL HEMATOLOGY 30(2):108-115
Bagnis C; Chabannon C; Gravis G; Imbert AM; Maroc C; Bardin F; Ladaique P; Viret F; Genre D; Faucher C; Stoppa AM; Vey N; Blaise D; Maraninchi D; Viens P; Mannoni P
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in in patients with breast or ovarian cancer receiving high-dose chemotherapy | | 0
|
| 0 | 232 2002 FERTILITY AND STERILITY 77(4):645-657
Stribley JM; Rehman KS; Niu HR; Christman GM
Gene therapy and reproductive medicine | | 0
|
| 1 | 233 2002 GENE THERAPY 9(8):477-487
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmuller U
Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors | | 0
|
| 3 | 234 2002 GENE THERAPY 9(11):653-657
Gruenert DC; Novelli G; Dallapiccola B; Colosimo A
Genome medicine: gene therapy for the millennium, 30 September 3 October 2001, Rome, Italy - Overview | | 0
|
| 0 | 235 2002 GENE THERAPY 9(11):700-702
Thorpe P; Stevenson BJ; Porteous DJ
Optimising gene repair strategies in cell culture | | 0
|
| 0 | 236 2002 GENE THERAPY METHODS 346():466-500
Rohll JB; Mitrophanous KA; Martin-Rendon E; Ellard FM; Radcliffe PA; Mazarakis ND; Kingsman SM
Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors | | 0
|
| 2 | 237 2002 HAEMOPHILIA 8(3):255-260
Karlsson S; Ooka A; Woods NB
Development of gene therapy for blood disorders by gene transfer into haematopoietic stem cells | | 0
|
| 2 | 238 2002 HUMAN GENE THERAPY 13(2):233-242
Schiedlmeier B; Schilz AJ; Kuhlcke K; Laufs S; Baum C; Zeller WJ; Eckert HG; Fruehauf S
Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice | | 0
|
| 3 | 239 2002 HUMAN GENE THERAPY 13(5):579-604
Hsich G; Sena-Esteves M; Breakefield XO
Critical issues in gene therapy for neurologic disease | | 0
|
| 0 | 240 2002 INTERNATIONAL JOURNAL OF HEMATOLOGY 75(3):228-236
Emery DW; Nishino T; Murata K; Fragkos M; Stamatoyannopoulos G
Hematopoietic stem cell gene therapy | | 0
|
| 1 | 241 2002 INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 213 213():93-146
Baum BJ; Wellner RB; Deng CY
Gene transfer to salivary glands | | 0
|
| 0 | 242 2002 ISSUES IN LAW & MEDICINE 17(3):293-307
[Anon]
A review of the National Institute of Health's "guidelines for research using human pluripotent stem cells" | | 0
|
| 5 | 243 2002 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 109(5):747-757
Buckley RH
Primary cellular immunodeficiencies | | 0
|
| 3 | 244 2002 JOURNAL OF CELLULAR BIOCHEMISTRY ():46-54
Medin JA; Fowler DH
Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: Beyond efficiency issues | | 0
|
| 0 | 245 2002 JOURNAL OF CELLULAR BIOCHEMISTRY ():55-64
Becker PS
Hematopoietic stem cell gene therapy for inherited bone marrow disorders: Past accomplishments and continued challenges | | 0
|
| 1 | 246 2002 JOURNAL OF GENE MEDICINE 4(1):5-13
Saffery R; Choo KHA
Strategies for engineering human chromosomes with therapeutic potential | 1 | 0
|
| 3 | 247 2002 JOURNAL OF GENE MEDICINE 4(2):113-121
Sadelain M
Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy | | 0
|
| 0 | 248 2002 JOURNAL OF GENE MEDICINE 4(2):122-132
Relander T; Karlsson S; Richter J
Oncoretroviral gene transfer to NOD/SCID repopulating cells using three different viral envelopes | | 0
|
| 1 | 249 2002 JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH 11(2):327-336
Ravet E; Dubart-Kupperschmitt A; Robin C; Titeux M; Coulombel L; Pflumio F
Successful transduction of human multipotent, lymphoid (T, B, NK) and myeloid, and transplantable CD34(+)CD38(low) cord blood cells using a murine oncoretroviral vector | | 0
|
| 3 | 250 2002 JOURNAL OF THE AMERICAN DENTAL ASSOCIATION 133(1):35-44
Baum BJ; Kok M; Tram SD; Yamano S
The impact of gene therapy on dentistry - A revisiting after six years | | 0
|
| 0 | 251 2002 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 13(1):S117-S124
Hoff CM; Shockley TR
Peritoneal dialysis in the 21st century: The potential of gene therapy | | 0
|
| 1 | 252 2002 JOURNAL OF THE NATIONAL CANCER INSTITUTE 94(10):741-749
Hemminki A; Zinn KR; Liu B; Chaudhuri TR; Desmond RA; Rogers BE; Barnes MN; Alvarez RD; Curiel DT
In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus | 1 | 0
|
| 1 | 253 2002 LANCET ONCOLOGY 3(3):154-158
Banerjee D; Bertino JR
Myeloprotection with drug-resistance genes | | 0
|
| 1 | 254 2002 LENTIVIRAL VECTORS 261():53-74
Negre D; Duisit G; Mangeot PE; Moullier P; Darlix JL; Cosset FL
Lentiviral vectors derived from simian immunodeficiency virus | | 0
|
| 1 | 255 2002 LENTIVIRAL VECTORS 261():107-121
Zufferey R
Production of lentiviral vectors | | 0
|
| 0 | 256 2002 LENTIVIRAL VECTORS 261():143-163
Larochelle A; Peng KW; Russell SJ
Lentiviral vector targeting | | 0
|
| 1 | 257 2002 LENTIVIRAL VECTORS 261():211-227
Salmon P; Trono D
Lentiviral vectors for the gene therapy of lympho-hematological disorders | | 0
|
| 0 | 258 2002 LENTIVIRAL VECTORS 261():229-243
Amado RG; Chen ISY
Lentiviral vectors for gene therapy of HIV-Induced disease | | 0
|
| 0 | 259 2002 LENTIVIRAL VECTORS 261():245-254
Galimi F; Verma IM
Opportunities for the use of lentiviral vectors in human gene therapy | | 0
|
| 3 | 260 2002 LEUKEMIA 16(4):563-569
Woods NB; Ooka A; Karlsson S
Development of gene therapy for hematopoietic stem cells using lentiviral vectors | | 0
|
| 0 | 261 2002 M S-MEDECINE SCIENCES 18(4):503-509
Kahn A
From biology to ethics (1) - Stem cells and regenerative medicine | | 0
|
| 0 | 262 2002 MEDICAL AND PEDIATRIC ONCOLOGY 38(5):305-309
Henter JI
Biology and treatment of familial hemophagocytic lymphohistiocytosis: Importance of perforin in lymphocyte- mediated cytotoxicity and triggering of apoptosis | | 0
|
| 1 | 263 2002 MEDICINE 81(1):69-86
Balicki D; Beutler E
Gene therapy of human disease | | 0
|
| 1 | 264 2002 MOLECULAR THERAPY 5(2):96-97
Kohn DB
Adenosine deaminase gene therapy protocol revisited | | 0
|
| 2 | 265 2002 MOLECULAR THERAPY 5(3):242-251
Hanawa H; Kelly PF; Nathwani AC; Persons DA; Vandergriff JA; Hargrove P; Vanin EF; Nienhuis AW
Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood | | 0
|
| 2 | 266 2002 MOLECULAR THERAPY 5(3):316-322
Kluge KA; Bonifacino AC; Sellers S; Agricola BA; Donahue RE; Dunbar CE
Retroviral transduction and engraftment ability of primate hematopoietic progenitor and stem cells transduced under serum- free versus serum-containing conditions | | 0
|
| 1 | 267 2002 MOLECULAR THERAPY 5(4):473-478
Kuhlcke K; Fehse B; Schilz A; Loges S; Lindemann C; Ayuk F; Lehmann F; Stute N; Fauser AA; Zander AR; Eckert HG
Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels | | 0
|
| 3 | 268 2002 NATURE IMMUNOLOGY 3(4):318-321
Bordignon C; Roncarolo MG
Therapeutic applications for hematopoietic stem cell gene transfer | | 0
|
| 0 | 269 2002 NEUROREPORT 13(6):743-743
Monville C
Gene therapy in Parkinson's disease: Dream or reality? | | 0
|
| 0 | 270 2002 NEW ENGLAND JOURNAL OF MEDICINE 346(16):1185-1193
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay J; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Cavazzana-Calvo M; Davies EG; Kuis W; Lundlaan WHK; Leiva L
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy | 1 | 0
|
| 0 | 271 2002 NUCLEIC ACIDS RESEARCH 30(1):232-234
Valiaho J; Pusa M; Ylinen T; Vihinen M
IDR: The ImmunoDeficiency resource | | 0
|
| 2 | 272 2002 ONCOGENE 21(21):3274-3283
Shi PA; Hematti P; von Kalle C; Dunbar CE
Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model | | 0
|
| 0 | 273 2002 PEDIATRIC RESEARCH 51(1):119-123
Buckley RH
American Pediatric Society Presidential Address 2000: Reflections on the 20th and 21st Centuries | | 0
|
| 0 | 274 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(5):3123-3128
Licht T; Haskins M; Henthorn P; Kleiman SE; Bodine DM; Whitwam T; Puck JM; Gottesman MM; Melniczek JR
Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma-chain and multidrug resistance (MDR1) transgenes in canine bone marrow | | 0
|
| 2 | 275 2002 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 55(3):238-241
Fischer A
Primary immunodeficiency diseases: Natural mutant models for the study of the immune system | | 0
|
| 0 | 276 2002 THROMBOSIS AND HAEMOSTASIS 87(3):362-363
Brown MA
Platelets: A new target for gene therapy of haemophilia B | | 0
|
| 0 | 277 2002 THROMBOSIS AND HAEMOSTASIS 87(3):366-373
Rodriguez MH; Enjolras N; Plantier JL; Rea M; Leboeuf M; Uzan G; Bordet JC; Negrier C
Expression of coagulation factor IX in a haematopoietic cell line | | 0
|
| 2 | 278 2002 TIJDSCHRIFT VOOR DIERGENEESKUNDE 127(2):52-56
Vulto AG; Pluim MAL
Clinical gene therapy: genes by prescription? | | 0
|
| 0 | 279 2002 TOXICOLOGY 174(1):13-19
Christ M
Preclinical evaluation of gene transfer products: safety and immunological aspects | | 0
|